0455.HK - Tianda Pharmaceuticals Limited

HKSE - HKSE Delayed Price. Currency in HKD
Currency in HKD

Valuation Measures

Market Cap (intraday) 5
419.68M
Enterprise Value 3
-8.07M
Trailing P/E
157.50
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
0.80
Price/Book (mrq)
0.52
Enterprise Value/Revenue 3
-0.01
Enterprise Value/EBITDA 6
-0.32

Trading Information

Stock Price History

Beta (3Y Monthly) 1.04
52-Week Change 3-18.18%
S&P500 52-Week Change 313.33%
52 Week High 30.260
52 Week Low 30.172
50-Day Moving Average 30.189
200-Day Moving Average 30.208

Share Statistics

Avg Vol (3 month) 378.96k
Avg Vol (10 day) 384.5k
Shares Outstanding 52.15B
Float 466.95M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 40.60%
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.53%
5 Year Average Dividend Yield 4N/A
Payout Ratio 4291.67%
Dividend Date 3N/A
Ex-Dividend Date 4Sep 2, 2019
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2019
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.50%
Operating Margin (ttm)1.75%

Management Effectiveness

Return on Assets (ttm)0.57%
Return on Equity (ttm)1.88%

Income Statement

Revenue (ttm)527M
Revenue Per Share (ttm)0.25
Quarterly Revenue Growth (yoy)11.10%
Gross Profit (ttm)424.08M
EBITDA 25.4M
Net Income Avi to Common (ttm)2.66M
Diluted EPS (ttm)0.001
Quarterly Earnings Growth (yoy)-97.90%

Balance Sheet

Total Cash (mrq)448.19M
Total Cash Per Share (mrq)0.21
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.04
Book Value Per Share (mrq)0.36

Cash Flow Statement

Operating Cash Flow (ttm)19.17M
Levered Free Cash Flow (ttm)-117.57M